Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Affimed N.V.
AFMD
$
3.31
3.1%
Thu October 22nd, 2020
11:26
Analysis
OraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Tue August 11th, 2020
15:41
Earnings
Analysis
Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
11:55
Analysis
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates
Zacks
+ 1 more
Wed July 29th, 2020
16:33
Earnings
Analysis
Affimed N.V. (AFMD) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Zacks
Fri July 24th, 2020
15:12
Analysis
Affimed's Innate Immune Programs Offer A Compelling Value At Current Price Levels
Seeking Alpha
Wed July 1st, 2020
16:58
Analysis
Affimed: Updates To Thesis, Time To Gain Exposure To Innate Immuno-Oncology
Seeking Alpha
Tue June 30th, 2020
15:03
Analysis
Will Affimed Continue to Surge Higher?
Zacks
Mon June 29th, 2020
12:43
Analysis
Implied Volatility Surging for Affimed (AFMD) Stock Options
Zacks
+ 1 more
Tue June 23rd, 2020
20:30
Earnings
Analysis
Affimed N.V. (AFMD) Q1 2020 Earnings Call Transcript
The Motley Fool
14:50
Earnings
Analysis
Affimed N.V. (AFMD) CEO Adi Hoess on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha
+ 1 more
Tue June 16th, 2020
13:47
Analysis
Affimed (AFMD) Catches Eye: Stock Jumps 7.2%
Zacks
